Answer
Yes, bosutinib monohydrate may cause a clinically significant decline in kidney function in adults and children with CML, so renal function should be assessed before treatment and closely monitored during therapy.
Sources for this answer
- Bosulif 500mg Film Coated TabletsPfizer Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 31Document updated
Sources checked